Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice

Hypertension Research

Volumn 36, Issue 11, 2013, Pages 934-939

  Nishioka, Satoshi ^a   Yoshioka, Toshitaka ^a   Nomura, Atsuo ^a   Kato, Ryuji ^a   Miyamura, Masatoshi ^a   Okada, Yoshikatsu ^a   Ishizaka, Nobukazu ^a   Matsumura, Yasuo ^a   Hayashi, Tetsuya ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

celiprolol; intermittent hypoxia; oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ARGINASE; ARGINASE 2; BRAIN NATRIURETIC PEPTIDE; CELIPROLOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; OXYGEN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MONITORING; CELL SIZE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HEART HEMODYNAMICS; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; INTERMITTENT HYPOXIA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TELEMETRY;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANOXIA; BLOOD PRESSURE; CELIPROLOL; HEART; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; SUPEROXIDES; VENTRICULAR REMODELING;

EID: 84887189533     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.60     Document Type: Article

References (34)

1. Lattimore JD, David S, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003; 41: 1429-1437.
2. Kato M, Adachi T, Koshino Y, Virend K. Obstructive sleep apnea and cardiovascular disease. Circ J 2009; 73: 1363-1370.
3. Nakashima H, Katayama T, Takagi C, Amenomori K, Ishizaki M, Honda Y. Obstructive sleep apnea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 2006; 27: 2317-2322.
4. Alchanatis M, Tourkohoriti G, Kosmas EN, Panoutsopoulos G, Kokouros S, Papadima K, Gaga M, Jordanoglou JB. Evidence for left ventricular dysfunction in patients with obstructive sleep apnea syndrome. Eur Respir J 2002; 20: 1239-1245.
5. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 2003; 7: 105-110.
6. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667.
7. Siwik DA, Tzortzis JD, Pimental DR, Chang DLF, Pagano PJ, Singh K, Sawyer DB, Coucci WS. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999; 85: 147-153.
8. Hayashi T, Yamashita C, Matsumoto C, Kwak CJ, Fujii K, Hirata T, Miyamura M, Mori T, Ukimura A, Okada Y, Matsumura Y, Kitaura Y. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol 2008; 294: 2197-2203.
9. Yamashita C, Hayashi T, Mori T, Tazawa N, Kwak CJ, Nakano D, Sohmiya K, Okada Y, Kitaura Y, Matsumura Y. Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice. Hypertens Res 2007; 30: 1219-1230.
10. Matsumoto C, Hayashi T, Kitada K, Yamashita C, Miyamura M, Mori T, Ukimura A, Ohkita M, Jin D, Takai S, Miyazaki M, Okada Y, Kitaura Y, Matsumura Y. Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice. Hypertension 2009; 54: 164-171.
11. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
12. Kakoki M, Hirata Y, Hayakawa H, Nishimatsu H, Suzuki Y, Nagata D, Suzuki E, Kikuchi K, Nagano T, Omata M. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney. Hypertension 1999; 33: 467-471.
13. Yao EH, Fukuda N, Matsumoto T, Katakawa M, Yamamoto C, Han Y, Ueno T, Kobayashi N, Matsumoto K. Effects of the antioxidative beta-blocker celiprolol on endothelial progenitor cells in hypertensive rats. Am J Hypertens 2008; 21: 12.
14. Mehta JL, Lopez LM, Chen L, Cox OE. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am J Cardiol 1994; 7: 901-905.
15. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298-1305.
16. Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamato S, Okuda N, Mori T, Sohmiya K, Kitarura Y, Okada Y, Matsumura Y. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res 2005; 28: 837-845.
17. Inamoto S, Yoshioka T, Yamashita C, Miyamura M, Mori T, Ukimura A, Matsumoto C, Matsumura Y, Kitaura Y, Hayashi T. Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice. Hypertens Res 2010; 33: 579-586.
18. Hayashi T, Yoshioka T, Hasegawa K, Miyamura M, Mori T, Ukimura A, Matsumura Y, Ishizaka N. Inhalation of hydrogen gas attenuates left ventricular remodeling induced by intermittent hypoxia in mice. Am J Physiol Heart Circ Physiol 2011; 301: 1062-1069.
19. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001; 283: 923-927.
20. Morris CR, Morris SM Jr, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003; 168: 63-69.
21. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004; 44: 935-943.
22. Lopez V, Siques P, Brito J, Vallejos C, Naveas N, Carvallo C, León-Velarde F, Carvajal N. Upregulation of arginase expression and activity in hypertensive rats exposed to chronic intermittent hypobaric hypoxia. High Alt Med Biol 2009; 10: 373-381.
23. Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG, Santhanam L, Webb A, Camara A, Sikka G, Nyhan D, Shoukas AA, Ilies M, Christianson DW, Champion HC, Berkowitz DE. Arginase inhibiton restores NOS coupling and reverses endothelial dysfunction and vascular stiffnes in old rats. J Appl Physiol 2009; 107: 1249-1257.
24. Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Shirataki H, Matsuoka H. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 2001; 19: 795-801.
25. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD, Nauqhton MT. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003; 18: 1396-1400.
26. Bradley TD, Tkacova R, Hall MJ, Ando S, Floras JS. Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Sci 2003; 104: 231-238.
27. Hui AS, Striet JB, Gudelsky G, Soukhova GK, Gozal E, Beitner-Johnson D, Gup SZ, Sachleben LR Jr, Haycock JW, Gozal D, Czyzyk-krzeska MF. Regulation of catechola-mines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 2003; 42: 1130-1136.
28. Li S, Qian XH, Zhou W, Zhang Y, Feng J, Wan NS, Zhang Z, Guo R, Chen BY. Time-dependent inflammatory factor production and NFkB activation in a rodent model of intermittent hypoxia. Swiss Med Wkly 2011; 141: 13309-13320.
29. Kobayashi N, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nakano S, Tsubokou Y, Matsuoka H. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kB induced by oxidative stress. Hypertension 2003; 42: 1004-1013.
30. Konno S, Hirooka Y, Kishi T, Sunagawa K. Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats. J Hypertens 2012; 30: 1992-1999.
31. Taguchi I, Toyoda S, Takano K, Arikawa T, Kikuchi M, Ogawa M, Abe S, Node K, Inoue T. Irbesartan, an angiotension receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension. Hypertens Res 2013; 36: 608-613.
32. Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D, Matsumura Y, Okuda N, Sohmiya K, Sakai A, Furuya E, Kitaura Y. Angiotensin II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circ J 2006; 70: 787-792.
33. Mori T, Hayashi T, Sohmiya K, Okuda N, Shimomura H, Ohkita M, Matsumura Y, Yoshiyama M, Yoshikawa J, Kitaura Y. Mechanisms of combined treatment with celiprolol and cabdesartan for ventricular remodeling in experimental heart failure. Circ J 2005; 69: 596-602.
34. Yamashita C, Hayashi T, Mori T, Matsumoto C, Kitada K, Miyamura M, Sohmiya K, Ukimura A, Okada Y, Yoshioka T, Kitaura Y, Matsumura Y. Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice. Life Sci 2010; 86: 322-330.